977 related articles for article (PubMed ID: 19959782)
21. Fibroblasts in myocardial infarction: a role in inflammation and repair.
Shinde AV; Frangogiannis NG
J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
[TBL] [Abstract][Full Text] [Related]
22. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
23. Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.
Schena GJ; Murray EK; Hildebrand AN; Headrick AL; Yang Y; Koch KA; Kubo H; Eaton D; Johnson J; Berretta R; Mohsin S; Kishore R; McKinsey TA; Elrod JW; Houser SR
Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1014-H1029. PubMed ID: 34623184
[TBL] [Abstract][Full Text] [Related]
24. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
[TBL] [Abstract][Full Text] [Related]
25. Cardiac fibroblasts: at the heart of myocardial remodeling.
Porter KE; Turner NA
Pharmacol Ther; 2009 Aug; 123(2):255-78. PubMed ID: 19460403
[TBL] [Abstract][Full Text] [Related]
26. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.
Banerjee I; Fuseler JW; Intwala AR; Baudino TA
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1694-704. PubMed ID: 19234091
[TBL] [Abstract][Full Text] [Related]
27. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis.
MacKenna D; Summerour SR; Villarreal FJ
Cardiovasc Res; 2000 May; 46(2):257-63. PubMed ID: 10773229
[TBL] [Abstract][Full Text] [Related]
28. The dynamic role of cardiac fibroblasts in development and disease.
Lajiness JD; Conway SJ
J Cardiovasc Transl Res; 2012 Dec; 5(6):739-48. PubMed ID: 22878976
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.
Villalobos E; Criollo A; Schiattarella GG; Altamirano F; French KM; May HI; Jiang N; Nguyen NUN; Romero D; Roa JC; García L; Diaz-Araya G; Morselli E; Ferdous A; Conway SJ; Sadek HA; Gillette TG; Lavandero S; Hill JA
Circulation; 2019 May; 139(20):2342-2357. PubMed ID: 30818997
[TBL] [Abstract][Full Text] [Related]
30. Defining the Cardiac Fibroblast.
Ivey MJ; Tallquist MD
Circ J; 2016 Oct; 80(11):2269-2276. PubMed ID: 27746422
[TBL] [Abstract][Full Text] [Related]
31. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.
Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399
[TBL] [Abstract][Full Text] [Related]
32. The dynamics of fibroblast-myocyte-capillary interactions in the heart.
Bowers SL; Borg TK; Baudino TA
Ann N Y Acad Sci; 2010 Feb; 1188():143-52. PubMed ID: 20201897
[TBL] [Abstract][Full Text] [Related]
33. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast-mediated pathways in cardiac hypertrophy.
Fujiu K; Nagai R
J Mol Cell Cardiol; 2014 May; 70():64-73. PubMed ID: 24492068
[TBL] [Abstract][Full Text] [Related]
35. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy.
Manabe I; Shindo T; Nagai R
Circ Res; 2002 Dec; 91(12):1103-13. PubMed ID: 12480810
[TBL] [Abstract][Full Text] [Related]
36. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
[TBL] [Abstract][Full Text] [Related]
37. Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production.
Sawaki D; Czibik G; Pini M; Ternacle J; Suffee N; Mercedes R; Marcelin G; Surenaud M; Marcos E; Gual P; Clément K; Hue S; Adnot S; Hatem SN; Tsuchimochi I; Yoshimitsu T; Hénégar C; Derumeaux G
Circulation; 2018 Aug; 138(8):809-822. PubMed ID: 29500246
[TBL] [Abstract][Full Text] [Related]
38. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.
Kong P; Christia P; Saxena A; Su Y; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1363-72. PubMed ID: 23997102
[TBL] [Abstract][Full Text] [Related]
39. Cardiac fibroblast in development and wound healing.
Deb A; Ubil E
J Mol Cell Cardiol; 2014 May; 70():47-55. PubMed ID: 24625635
[TBL] [Abstract][Full Text] [Related]
40. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
